Psychopharmacology what do the terms "drug-specific response/remission rate" and "placebo" really mean?

Journal of Psychiatric Practice

Volumn 17, Issue 6, 2011, Pages 420-424

  Preskorn, Sheldon H ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b WICHITA STATE UNIVERSITY   (United States)

Author keywords

Antidepressants; Placebo; Remission rate; Response rate

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; PLACEBO; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ARTICLE; CLINICAL RESEARCH; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFICACY; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MENTAL DISEASE; PLACEBO EFFECT; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; REMISSION; TREATMENT RESPONSE; CLINICAL TRIAL (TOPIC); REVIEW; TREATMENT OUTCOME;

ANTIDEPRESSIVE AGENTS; CLINICAL TRIALS AS TOPIC; DEPRESSIVE DISORDER, MAJOR; HUMANS; PLACEBO EFFECT; PLACEBOS; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 84856286249     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000407965.34604.4a     Document Type: Article

References (7)

1. Angell M. The illusions of psychiatry. The New York Review of Books, July 14, 2011 (available at www.nybooks.com/articles/archives/2011/jul/14/illusions- of-psychiatry, accessed September 6, 2011).
2. Oldham J, Carlat D, Friedman R, Nierenberg AA. The illusions of psychiatry: An exchange. The New York Review of Books, August 18, 2011 (available at www.nybooks.com/articles/archives/2011/aug/18/illusions- psychiatryexchange, accessed September 6, 2011).
3. Janicak P, Davis J, Preskorn S, et al. Principles and practice of psychopharmacotherapy, 4th edition. Baltimore, MD: Williams & Wilkins; 2006.
4. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-96.
5. To monitor or not to monitor, II. The glass is more than half full. Journal of Practical Psychiatry and Behavioral Health 1996;2:307-10.
6. ®D Project results: A comprehensive review of findings. Curr Psychiatry Rep 2007;9; 449-59. (Pubitemid 350284935)
7. *D Study: Implications for clinicians and drug developers. J Psychiatr Pract 2009;15:45-9.